Alpha DNA Investment Management’s Newmark Group NMRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-79,271
Closed -$1.26M 151
2022
Q1
$1.26M Buy
+79,271
New +$1.29M 0.89% 37
2021
Q2
Sell
-300
Closed -$3K 448
2021
Q1
$3K Buy
+300
New +$2.69K ﹤0.01% 491

Other funds holding NMRK

Alpha DNA Investment Management's NMRK Position: Q2 2022 in Review

Alpha DNA Investment Management sold out of Newmark Group (NMRK) in Q2 2022, closing a stake of 79,271 shares — an estimated $1.26M sold.

Alpha DNA Investment Management first reported a position in NMRK in Q1 2021 and held it in 2 quarters. The position peaked at $1.26M in Q1 2022. 211 funds tracked by Wall St. Rank hold NMRK as of Q2 2022.

  • Alpha DNA Investment Management reported no remaining Newmark Group position as of Q2 2022 after selling out during the quarter.
  • Alpha DNA Investment Management sold 79,271 Newmark Group shares in Q2 2022, an estimated $1.26M.
  • Alpha DNA Investment Management first reported a position in Newmark Group in Q1 2021 and held it in 2 quarters.
  • Alpha DNA Investment Management's Newmark Group position peaked at $1.26M in Q1 2022.
  • 211 funds tracked by Wall St. Rank held Newmark Group as of Q2 2022.

Based on Alpha DNA Investment Management's 13F filing for Q2 2022, filed 11 Aug 2022.